IMMUNOVANT INC. - COMMON STOCK
23,48
10-января-25 15:45:00
15 мин. задержка
Акции
-0,15
-0,63%
Сегодняшний диапазон
23,08 - 23,66
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
30 дек 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Present at the Stifel 2021 Virtual Healthcare Conference
12 ноя 2021 11:18:05 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended September 30, 2021
05 ноя 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Participate in Roivant R&D Day 2021
27 сен 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant Appoints Renee Barnett as Chief Financial Officer
15 сен 2021 06:00:01 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended June 30, 2021
09 авг 2021 05:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Report Financial Results for Quarter Ended June 30, 2021
06 авг 2021 15:22:27 Источник Nasdaq GlobeNewswire
-
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
02 авг 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
01 июн 2021 06:31:18 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
16 фев 2021 07:00:04 Источник Nasdaq GlobeNewswire
-
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
02 фев 2021 05:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
12 янв 2021 16:00:00 Источник Nasdaq GlobeNewswire